Kerala’s Snakebite Crisis: Gaps in ASV Use, SARPA Programme & Need for Rapid Diagnostics

<p>Kerala faces a growing public‑health challenge as snakebite deaths rise despite the widespread availability of <span class="key-term" data-definition="Anti‑snake venom — serum containing antibodies used to neutralise snake venom; crucial for managing envenomation cases (GS3: Health).">ASV</span>. The problem stems from ecological factors, clinical decision‑making uncertainties, and infrastructural shortfalls that together undermine the effectiveness of treatment.</p> <h3>Key Developments</h3> <ul> <li>Hotter pre‑monsoon summers drive <span class="key-term" data-definition="Ectothermic — organisms that rely on external heat sources to regulate body temperature; snakes are ectothermic, influencing their behaviour (GS3: Biology).">ectothermic</span> snakes into homes and storerooms, increasing human contact.</li> <li>The <strong>Indian Council of Medical Research (ICMR)</strong> has highlighted the flaws of the current <span class="key-term" data-definition="Syndromic approach — diagnosing based on clinical symptoms without laboratory confirmation; used for snakebite but may delay treatment (GS3: Health).">syndromic approach</span>, which relies on symptoms that appear after irreversible tissue damage.</li> <li>Kerala’s <span class="key-term" data-definition="SARPA — State Action for Rescue and Prevention of Accidents, a Kerala programme to professionalise snake rescue and awareness (GS2: Governance).">SARPA</span> initiative has made snakebite a notifiable disease and launched rescue‑training programmes, yet mortality remains high.</li> <li>Administration of <span class="key-term" data-definition="Anti‑snake venom — serum containing antibodies used to neutralise snake venom; crucial for managing envenomation cases (GS3: Health).">ASV</span> carries a risk of <span class="key-term" data-definition="Anaphylaxis — severe, rapid allergic reaction that can be fatal; a risk when administering ASV (GS3: Health).">anaphylaxis</span>, complicating treatment decisions.</li> </ul> <h3>Important Facts</h3> <p>India records nearly 50% of global snakebite incidents, with agricultural workers and children most vulnerable. Kerala alone hosts over 100 snake species, including the “<strong>Big Four</strong>” venomous snakes – the common krait, Russell’s viper, saw‑scaled viper and spectacled cobra. Approximately 70% of bites involve non‑venomous snakes, and half of the venomous bites are “dry” (no venom injected), meaning many patients do not require <span class="key-term" data-definition="Anti‑snake venom — serum containing antibodies used to neutralise snake venom; crucial for managing envenomation cases (GS3: Health).">ASV</span>. However, the lack of a rapid diagnostic kit forces clinicians to rely on symptom‑based assessment, often leading to delayed or unnecessary treatment.</p> <p>Compounding the issue are scarce ICU beds, limited ventilator backups, inadequate training in managing <span class="key-term" data-definition="Anaphylaxis — severe, rapid allergic reaction that can be fatal; a risk when administering ASV (GS3: Health).">anaphylaxis</span>, and insufficient laboratory support for monitoring patients.</p> <h3>UPSC Relevance</h3> <p>For GS‑3 (Health) candidates, the case illustrates the intersection of epidemiology, health‑policy implementation, and clinical governance. It underscores the need for robust disease‑surveillance (notifiable disease status) and the challenges of translating policy (SARPA programmes) into effective on‑ground outcomes. GS‑2 (Polity) aspirants can examine state‑level health governance, inter‑departmental coordination, and the role of central bodies like <span class="key-term" data-definition="Indian Council of Medical Research — India's apex body for biomedical research, which sets guidelines for clinical practice (GS3: Health).">ICMR</span> in setting standards. The environmental dimension (snake behaviour linked to climate) also touches on GS‑3 (Environment) considerations.</p> <h3>Way Forward</h3> <ul> <li>Develop and deploy rapid venom‑detection kits to replace the <span class="key-term" data-definition="Syndromic approach — diagnosing based on clinical symptoms without laboratory confirmation; used for snakebite but may delay treatment (GS3: Health).">syndromic approach</span>, enabling timely and accurate <span class="key-term" data-definition="Anti‑snake venom — serum containing antibodies used to neutralise snake venom; crucial for managing envenomation cases (GS3: Health).">ASV</span> administration.</li> <li>Expand ICU capacity and ensure backup ventilators in high‑risk districts, especially during the pre‑monsoon breeding season (April‑May).</li> <li>Strengthen training programmes for healthcare workers on recognising envenomation, managing <span class="key-term" data-definition="Anaphylaxis — severe, rapid allergic reaction that can be fatal; a risk when administering ASV (GS3: Health).">anaphylaxis</span>, and judicious use of <span class="key-term" data-definition="Anti‑snake venom — serum containing antibodies used to neutralise snake venom; crucial for managing envenomation cases (GS3: Health).">ASV</span>.</li> <li>Continue public‑awareness campaigns through <span class="key-term" data-definition="SARPA — State Action for Rescue and Prevention of Accidents, a Kerala programme to professionalise snake rescue and awareness (GS2: Governance).">SARPA</span> Padam and Suraksha, focusing on preventive measures and early reporting.</li> <li>Integrate climate‑adaptation strategies to address rising temperatures that push snakes into human habitats.</li> </ul> <p>Addressing these gaps will transform Kerala’s preventive focus into a balanced strategy that saves lives while optimising resource utilisation.</p>